FILE:MDT/MDT-8K-20020910103501.txt.gz
EVENTS:	Other events	Financial statements and exhibits
TEXT:
ITEM: Other events
ITEM: Financial statements and exhibits
Table of Contents
Table of Contents
Item 5. Other Events
On September 6, 2002, the Registrant issued a press release announcing that it had signed separate short-term bridge credit facilities with two financial institutions. The full text of the press release is set forth in Exhibit 99 which is attached hereto and incorporated in this Report as if fully set forth herein.
Item 7. Financial Statements and Exhibits
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Table of Contents

 
Exhibit 99
F O R   I M M E D I A T E   R E L E A S E
     MINNEAPOLIS, September 6, 2002  Medtronic, Inc. (NYSE: MDT) announced today that it has completed a private placement under Rule 144A of $500 million principal amount of its Floating Rate Notes due June 6, 2003, and has also entered into a short-term $500 million credit facility with a group of bank lenders.
     The net proceeds from the issuance of the notes and any borrowings under the credit facility, together with available cash, will be used by Medtronic, Inc. to repurchase its 1.25% Contingent Convertible Debentures due 2021 to the extent that the holders exercise their right to require Medtronic to repurchase the debentures on September 16, 2002. An aggregate of $2,012,500,000 principal amount of the debentures is currently outstanding.
     The notes have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States unless they are registered or unless such sale is exempt from the registration requirements of the Securities Act.


